VIRBAC has acquired a majority stake in CENTROVET, a leading Chilean animal health company, positioning itself as a key player in the growing aquaculture health market.
Information on the Target
CENTROVET is a leading player in the animal health market in Chile, renowned for its commitment to quality and innovation. The company's focus lies in providing effective health solutions specifically designed for aquaculture, making it an essential partner for fish farmers and the broader aquaculture industry.
By acquiring a majority stake in CENTROVET, VIRBAC positions itself strategically within this vital segment of animal health. The company specializes in protecting and treating aquatic species, thereby enhancing productivity and sustainability in aquaculture practices.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Chile
The aquaculture industry in Chile has witnessed significant growth in recent years, largely driven by the global demand for seafood. As the world's second-largest supplier of farmed salmon, Chile is at the
Similar Deals
Olympus Latin America → Sur Medical SpA
2025
Patria Investments and Linzor Capital → Banmédica
2025
Bambu Ventures → Lemonaid Health
2026
VIRBAC
invested in
CENTROVET
in 2012
in a Buyout deal